Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellcept in ART-naïve HIV patients (MAN2)
NCT00120419Phase 4Unknown
- Sponsor
- University of Amsterdam
- Start
- Apr 2005
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in human immunodeficiency virus infection (HIV), sponsored by University of Amsterdam. Primary endpoint: CD4+ T cell count at 48 weeks. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00120419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120419.